Skip to main content

Table 1 Summary of patient characteristics and endpoints in control and intervention group

From: Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial

 

Item

Control group (n = 29)

Intervention group (n = 31)

p-Value

Patient characteristics

Gender (female, %)

17 (58.6%)

19 (61.3%)

1.000

Living situation (home-cared, %)

22 (75%)

20 (64.5%)

0.4051

 

Age (mean, SD, range; years)

79.5 ± 8.62 (66–99)

75.9 ± 6.87 (66–91)

0.0856

 

Length of stay on ward (mean, SD, range; days)

10.1 ± 6.0 (3–29)

11.9 ± 8.5 (4–40)

0.0671

 

Number of drugs during hospital stay (mean, SD, range)

16.3 ± 6.3 (7–32)

17.3 ± 7.3 (6–40)

0.5649

Drug-related readmissions (DRRs)

Number

7

6

 

Number of patients with DRR

7

3

 

Adverse drug reactions (ADRs) during follow-up

Number

14

21

 

Number of preventable/ameliorable ADR (NCC-MERP category F-H) regarded as “preventable DRR”

4

1

 
 

Number of preventable/ameliorable ADR (NCC-MERP category D-E)

2

7

 

Adverse drug reactions (ADRs) during hospital stay

Number

9

9

 

Potential inappropriate medication (PIM)

One-year prevalence of PIM

20

31

 

Changes in medication after discharge during follow-up

Number per patient

16 ± 11 (3–47)

16 ± 10 (3–52)

 
  1. SD Standard deviation